Which could potentially drive down the costs of drugs in addition to having them on the market sooner for patients in need.Kath wrote: I believe Mr. Trump's pick for FDA wants to implement policy eliminating the requirement to prove efficacy of drug before taking it to market.
Not that I'm advocating that we start pumping out ineffective drugs to the populace, but removing the requirement for Phase 2 and 3 trials could easily be rolled into the Phase 4 trials, in addition to having efficacy data be a part of annual submissions that are already being made to the agency. It could still be beneficial.
